Originally Aired: March 10, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

The value of plasmid DNA in today’s biopharma industry cannot be overstated. Plasmid ubiquity can be seen in many therapeutic areas as they are widely used in cell and gene therapy, serve as raw materials for viral vector production and act as the delivery vehicle to transfer the gene of interest or the final drug product in the case of DNA vaccine. Yet, often manufacturing these vectors at scale can present challenges for organizations looking to focus their efforts on therapeutic outcomes rather than bioprocessing roadblocks. Thankfully, solutions abound.

In this GEN webinar, our distinguished speaker, Dr. Ming Ni, will discuss GenScript ProBio’s plasmid platform technologies designed for producing plasmid DNA in high yields using advanced methodologies. In addition, Dr. Ni will describe the GenScript teams’ capabilities for providing CDMO services from the preclinical plasmid preparation, through the IND application, to commercial products.

A live Q&A session followed the presentation, offering a chance to pose questions to our expert panelist.

probio logo

Ming Ni
Ming Ni, PhD
Principal Project Manager
GenScript ProBio


Comments are closed.